PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ASTHMA

PROBLEM TO BE SOLVED: To provide a formulation for treatment of asthma, free of CFC (chlorofluorocarbon), having desirable solubility, stability, low toxicity, accurate dosage, correct particle diameter and/or compatibility with conventionally used valve assembly of inhalator for measured dosage and...

Full description

Saved in:
Bibliographic Details
Main Authors SEQUEIRA JOEL A, HART JOHN L, SHARPE STEFAN A
Format Patent
LanguageEnglish
Published 20.08.2009
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a formulation for treatment of asthma, free of CFC (chlorofluorocarbon), having desirable solubility, stability, low toxicity, accurate dosage, correct particle diameter and/or compatibility with conventionally used valve assembly of inhalator for measured dosage and to provide a method for producing the formulation. SOLUTION: Disclosed are aerosolized formulations for the treatment of asthma (that contain mometasone furoate and formoterol fumarate) and methods for preparing the same. Accordingly, the present invention is directed to a process for producing non-toxic formulations that are substantially free of CFC's that have improved stability and compatibility with the medicament and which are relatively easily manufactured. The formulations are produced according to conventional procedure in the technological field in respect to other aerosol composition. Typically, all components other than the propellant are mixed and introduced into an aerosol container. COPYRIGHT: (C)2009,JPO&INPIT
Bibliography:Application Number: JP20090126933